SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-20-000040
Filing Date
2020-01-14
Accepted
2020-01-14 07:41:00
Documents
16
Period of Report
2019-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K aphria6k.htm 6-K 12071
2 Q2 FINANCIAL STATEMENTS ex991.htm EX-99.1 943858
3 MANAGEMENT'S DISCUSSION AND ANALYSIS ex992.htm EX-99.2 690957
4 CEO AND CFO CERTIFICATES ex993.htm EX-99.3 16559
5 GRAPHIC ex991_logo.jpg GRAPHIC 26355
6 GRAPHIC logo_footer.jpg GRAPHIC 2622
7 GRAPHIC mda_image1.jpg GRAPHIC 7074
8 GRAPHIC mda_image2.jpg GRAPHIC 53566
9 GRAPHIC mda_image3.jpg GRAPHIC 5363
10 GRAPHIC mda_image4.jpg GRAPHIC 3390
11 GRAPHIC mda_image5.jpg GRAPHIC 2458
12 GRAPHIC mda_image6.jpg GRAPHIC 5117
13 GRAPHIC mda_image7.jpg GRAPHIC 37164
14 GRAPHIC mda_image8.jpg GRAPHIC 28999
15 GRAPHIC mda_image9.jpg GRAPHIC 21992
16 GRAPHIC mda_image10.jpg GRAPHIC 16339
  Complete submission text file 0001279569-20-000040.txt   1955961
Mailing Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8
Business Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8 (844) 427-4742
Aphria Inc. (Filer) CIK: 0001733418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-38708 | Film No.: 20524971
SIC: 2833 Medicinal Chemicals & Botanical Products